Annals of vascular surgery · 2026
Predictive Value of 2D Phase Contrast Magnetic Resonance Imaging in Patients with Suspected Chronic Mesenteric Ischemia.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Jones Melissa, Mutwiri George, Obrand Jeremy, Rommens Kenton, Bandali Murad
Аннотация
BACKGROUND: The diagnosis of chronic mesenteric ischemia (CMI) is a clinical diagnosis of symptoms in setting of occlusive arterial disease. The study aimed to determine the predictive value of postprandial superior mesenteric vein (SMV) flow augmentation on two-dimensional phase contrast magnetic resonance imaging (2D PC-MR) as a measure of impaired perfusion in patients with suspected CMI.
METHODS: A retrospective review of all adult patients undergoing evaluation for CMI with 2D PC-MR at a single tertiary university care center between January 1, 2021, and January 1, 2025, was performed. Patients required 1 symptom (postprandial pain, weight loss, food fear) and anatomic disease consistent with CMI (isolated severe SMA stenosis or occlusion, or at least moderate 2 vessel-visceral disease including the SMA). A threshold of postprandial SMV flow augmentation less than 50% was chosen to represent abnormal physiologic response. The diagnosis of CMI was determined by a vascular surgeon. Descriptive statistics and contingency analysis were applied due to the small sample size.
RESULTS: Thirty-three patients were included in the study. Two-dimensional (2D) PC-MR demonstrated a sensitivity of 93% and a specificity of 68%. Positive predictive value was 68% and negative predictive value was 93%. Of the 3 patients diagnosed with CMI who underwent intervention and received a postprocedure 2D PC-MR study, all demonstrated symptom resolution and normalization of postprandial SMV flow augmentation.
CONCLUSION: A threshold of postprandial SMV flow augmentation less than 50% on 2D PC-MR was sensitive in detecting patients with CMI and demonstrated a good negative predictive value, suggesting it may be used as a screening tool in the future.
METHODS: A retrospective review of all adult patients undergoing evaluation for CMI with 2D PC-MR at a single tertiary university care center between January 1, 2021, and January 1, 2025, was performed. Patients required 1 symptom (postprandial pain, weight loss, food fear) and anatomic disease consistent with CMI (isolated severe SMA stenosis or occlusion, or at least moderate 2 vessel-visceral disease including the SMA). A threshold of postprandial SMV flow augmentation less than 50% was chosen to represent abnormal physiologic response. The diagnosis of CMI was determined by a vascular surgeon. Descriptive statistics and contingency analysis were applied due to the small sample size.
RESULTS: Thirty-three patients were included in the study. Two-dimensional (2D) PC-MR demonstrated a sensitivity of 93% and a specificity of 68%. Positive predictive value was 68% and negative predictive value was 93%. Of the 3 patients diagnosed with CMI who underwent intervention and received a postprocedure 2D PC-MR study, all demonstrated symptom resolution and normalization of postprandial SMV flow augmentation.
CONCLUSION: A threshold of postprandial SMV flow augmentation less than 50% on 2D PC-MR was sensitive in detecting patients with CMI and demonstrated a good negative predictive value, suggesting it may be used as a screening tool in the future.